Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignancies

British Journal of Haematology

Volumn 156, Issue 2, 2012, Pages 275-279

  Inaba, Hiroto ^a   Bhojwani, Deepa ^a   Pauley, Jennifer L ^a   Pei, Deqing ^a   Cheng, Cheng ^a   Metzger, Monika L ^a   Howard, Scott C ^a   Rubnitz, Jeffrey E ^a   Sandlund, John T ^a   Ribeiro, Raul C ^a   Leung, Wing ^a   Campana, Dario ^a,b   Pui, Ching Hon ^a,b   Jeha, Sima ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Childhood; Clofarabine; Leukaemia; Refractory; Relapsed

Indexed keywords

CLOFARABINE; CYCLOPHOSPHAMIDE; ETOPOSIDE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE KIDNEY FAILURE; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ANOREXIA; BRAIN DISEASE; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RELAPSE; CAUSE OF DEATH; CHILD; CLINICAL ARTICLE; CYTOGENETICS; DIARRHEA; DRUG FATALITY; DRUG RESPONSE; DYSPNEA; FEBRILE NEUTROPENIA; FEMALE; HEMATOLOGIC MALIGNANCY; HEMORRHAGIC CYSTITIS; HUMAN; HYPERBILIRUBINEMIA; HYPERTENSION; HYPOTENSION; INFANT; LETTER; MALE; MUCOSA INFLAMMATION; MYCOSIS; NAUSEA; PLEURA EFFUSION; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; SCHOOL CHILD; SEIZURE; SIDE EFFECT; T CELL LYMPHOMA;

ADENINE NUCLEOTIDES; ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARABINONUCLEOSIDES; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; ETOPOSIDE; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; INFANT; MALE;

EID: 84155189119     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08847.x     Document Type: Letter

References (8)

1. Bader, P., Kreyenberg, H., Henze, G.H., Eckert, C., Reising, M., Willasch, A., Barth, A., Borkhardt, A., Peters, C., Handgretinger, R., Sykora, K.W., Holter, W., Kabisch, H., Klingebiel, T. & von Stackelberg, A. (2009) Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group. Journal of Clinical Oncology, 27, 377-384.
2. Coustan-Smith, E., Sancho, J., Hancock, M.L., Boyett, J.M., Behm, F.G., Raimondi, S.C., Sandlund, J.T., Rivera, G.K., Rubnitz, J.E., Ribeiro, R.C., Pui, C.H. & Campana, D. (2000) Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood, 96, 2691-2696.
3. Faderl, S., Gandhi, V., O'Brien, S., Bonate, P., Cortes, J., Estey, E., Beran, M., Wierda, W., Garcia-Manero, G., Ferrajoli, A., Estrov, Z., Giles, F.J., Du, M., Kwari, M., Keating, M., Plunkett, W. & Kantarjian, H. (2005) Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias. Blood, 105, 940-947.
4. Hijiya, N., Gaynon, P., Barry, E., Silverman, L., Thomson, B., Chu, R., Cooper, T., Kadota, R., Rytting, M., Steinherz, P., Shen, V., Jeha, S., Abichandani, R. & Carroll, W.L. (2009) A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia. Leukemia, 23, 2259-2264.
5. Kurt, B., Flynn, P., Shenep, J.L., Pounds, S., Lensing, S., Ribeiro, R.C., Pui, C.H., Razzouk, B.I. & Rubnitz, J.E. (2008) Prophylactic antibiotics reduce morbidity due to septicemia during intensive treatment for pediatric acute myeloid leukemia. Cancer, 113, 376-382.
6. Locatelli, F., Testi, A.M., Bernardo, M.E., Rizzari, C., Bertaina, A., Merli, P., Pession, A., Giraldi, E., Parasole, R., Barberi, W. & Zecca, M. (2009) Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia. British Journal of Haematology, 147, 371-378.
7. O'Connor, D., Sibson, K., Caswell, M., Connor, P., Cummins, M., Mitchell, C., Motwani, J., Taj, M., Vora, A., Wynn, R. & Kearns, P.R. (2011) Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia. British Journal of Haematology, 154, 482-485.
8. Yamauchi, T., Nowak, B.J., Keating, M.J. & Plunkett, W. (2001) DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine. Clinical Cancer Research, 7, 3580-3589.